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James M Hughes1†, Beatrice Salvatori2†, Federico M Giorgi2, Irene Bozzoni1,3,4 and Alessandro Fatica1*Abstract
CCAAT/enhancer-binding protein-α (CEBPA) is a critical regulator of myeloid differentiation. Disruption of CEBPA
function contributes to the development of acute myeloid leukemia (AML). CEBPA regulates a large number of
protein coding genes of which several were shown to contribute to CEBPA function. In this study, we expand the
analysis of CEBPA transcriptional targets to the newly identified class of long non-coding RNAs. We show that
lncRNAs are a main component of the transcriptional program driven by C/EBPα and that many of these are also
induced during granulocytic differentiation of AML cell lines supporting their relevance in proliferation arrest and
differentiation.
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LncRNAs participate in multiple networks controlling cell
differentiation and development [1], with their expression
already associated with cancer and several disorders [2]. To
what degree C/EBPα regulates the expression of lncRNAs
is still largely unknown.
To investigate the effect of C/EBPα on the expression
of lncRNAs we utilized the K562 AML cell line carrying
a stable and Tet-on inducible CEBPA allele (Additional
file 1 and Additional file 2: Figure S1). K562 cells lack
endogenous C/EBPα and restoration of its expression in-
duces proliferation arrest and granulocytic differentiation
[3] (Additional file 1 and Additional file 2: Figure S1).
Based on the expression of known C/EBPα transcriptional
targets, we selected RNA extracted from 48 hours of in-
duction (K562-C/EBPα) together with RNA extracted
from control-induced cells (K562-CTR). Gene expression
profiling was performed using the Agilent Whole Human
Genome Oligo 8x60K v2 Microarrays from 4 biological
replicates for each sample (Figure 1A). We identified 4605
mRNAs (2643 induced and 1962 repressed) and 930
lncRNAs (600 induced and 330 repressed) with significant
differential expression (fold change ≥ 2 and p-value ≤ 0.05)
between C/EBPα- and CTR- induced cells (Figure 1B and* Correspondence: alessandro.fatica@uniroma1.it
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Appropriate expression patterns of many known coding
transcriptional targets of C/EBPα confirmed the reli-
ability of our gene expression analysis (Additional file 1
and Additional file 2: Figure S1). Gene set enrichment
and Gene ontology analysis confirmed significant en-
richment of known C/EBPα targets [4] (NES = 7.97,
p = 1.65×10−15), coupled with down-regulation of cell
cycle genes and upregulation of granulocytic differenti-
ation pathways (Figure 2). Notably, we found the E2F1
motif to be negatively enriched in the promoters of C/
EBPα repressed genes (NES = −7.18, p = 7.06×10−13),
confirming the known role of C/EBPα in repressing
E2F1 activity (Additional file 5: Figure S2). Expression
of differentially induced lncRNAs was further validated by
qRT-PCR in K562 -C/EBPα and -CTR cells (Figure 2A).
When applicable, official lncRNA reference names were
utilized. Otherwise, we refer to as lnc-CUs (lncRNA-C/
EBPα-up-regulated) and lnc-DCs (lncRNA-C/EBPα down-
regulated) for induced and repressed lncRNAs, respectively
(Additional file 1 and Additional file 6: Table S3).
In order to annotate the presence of putative C/EBPα
binding sites in the promoter of differentially expressed
genes, we used previously generated ChIP data sets for
CEBPB (C/EBPβ) and CEBPD (C/EBPδ) in K562 cells [5],l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 LncRNAs are a component of the C/EBPα-regulated transcriptional network in AML. (A) Experimental pipeline for identification of
C/EBPα-regulated lncRNAs. See text and Additional file 1 for details (B) Heat maps of median centered log2 fold change values from microarray
analysis of mRNAs and lncRNAs with significant differential expression (fold change ≥ 2 and adjusted p-value ≤ 0.05). Exact values are provided in
Additional files 3 and 4: Table S1 and Table S2. Presence of CEBPB or CEBPD binding sites is indicated on the side of each heat maps.
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http://www.jhoonline.org/content/7/1/69which exhibit identical DNA-binding specificities with
C/EBPα [6]. We found several coding and non-coding
differentially expressed genes bound by either CEBPB
or CEBPD in their putative promoter region within a
distance of −5 kb from the TSS (Figure 1B and
Additional file 1, Additional file 7: Figure S3, Additional
file 8: Table S4, Additional file 9: Table S5, Additional
file 10: Table S6 and Additional file 11: Table S7).
Different AML cell lines are widely used to study the
block of differentiation in AML because they can be dif-
ferentiated in mature and functional myeloid cells by
treatment with specific agents. Thus, we analysed the ex-
pression of selected lncRNAs in NB4 cells, which are
able to undergo granulocytic differentiation by treatment
with all-trans retinoic acid (ATRA) [7]. Notably, the ma-
jority of validated C/EBPα-induced lncRNAs in K562 are
also significantly upregulated by ATRA in NB4 (21 out
of 26), suggesting that they may play a role in the differ-
entiation process (Figure 2B). Nevertheless, upon vali-
dated lncRNAs repressed by C/EBPα treatment in K562,6 out of 8 showed opposite trend while 2 were not sig-
nificantly expressed in NB4 (data not shown). This be-
haviour still remains to be explained and extended to
the study of more lncRNAs in NB4 cell line: we specu-
late it could be due to silencing of diverse cellular set-
tings between K562 and NB4 cell lines.
In summary, this study shows that lncRNAs are a
main component of the transcriptional program driven
by C/EBPα. We identified more than 900 lncRNAs regu-
lated by C/EBPα in K562. We confirmed that the major-
ity of these are also induced during granulocytic
differentiation of AML cell lines supporting their rele-
vance in proliferation arrest and differentiation. How
many of the lncRNAs identified in this study are directly
involved in regulating differentiation programmes of
AML is an interesting question that warrants further
investigations.
Moreover, regardless of function, this work indicates
that changes in lncRNAs expression might also have
diagnostic applications in AML with CEBPA mutations.
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Figure 2 Validation of selected lncRNAs. (A) Quantitative real time RT-PCR analysis of selected lncRNAs in K562-C/EBPα treated for 48 hours
with doxycycline. Values were compared to K562-CTR cells treated for the same time and normalized with HPRT mRNA. The histograms represent
the log2 fold change of the relative expression ± SEM from three replicates. TCONS names and chromosomal positions are provided as Additional
file 6: Table S3. (B) Quantitative real time RT-PCR analysis of selected lncRNAs in NB4 cells treated for 72 hours with all-trans-retinoic acid (ATRA).
Values were compared to untreated NB4 cells and normalized with HPRT mRNA. The histograms represent the log2 fold change of the relative
expression ± SEM from three replicates.
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Additional file 1: Materials and methods.
Additional file 2: Figure S1. Effects of C/EBPα expression in K562 cells.
(A) Growth curve of K562 cells containing CTR and CEBPA expression
cassette, respectively, after induction with Doxycyline. As expected, cells
induced with C/EBPα cease to proliferate, while the CTR empty vector
cells continue to proliferate. (B) Western blot confirms the expression of
endogenous C/EBPα in the CEBPA stable cell line, and not in the CTR
empty vector cell line. (C) FACS analysis for the granulocytic marker
CD11b shows the percentage of positive cells within the given
population after 48 hours of Doxycycline induction. (D) qRT-PCR analysis
of the expression of the granulocytic marker GCSFR after 48 hrs of induction.
Values were normalized with HPRT mRNA. The histograms represent the
fold change of the relative expression ± SEM from three replicates. (E)
Known C/EBPα transcriptional targets identified in our microarray analysis.
Additional file 3: Table S1. CEBPA-regulated lncRNAs with significant
differential expression (absolute fold change ≥ 2 and adjusted P value ≤ 0.05)
identified in K562. (A) Up-regulated lncRNAs. (B) Down-regulated lncRNAs.
Additional file 4: Table S2. CEBPA-regulated mRNAs with significant
differential expression (absolute fold change ≥ 2 and adjusted P value ≤ 0.05)
identified in K562. (A) Up-regulated mRNAs. (B) Down-regulated mcRNAs.Additional file 5: Figure S2. GSEA on CEBPA-regulated mRNAs. The
enrichment score (ES; y-axis) reflects the degree to which a gene set is
overrepresented in K562 expressing CEBPA. Each solid bar represents 1
gene within a gene set. Lower panels (List values) illustrate log2 fold
change for the gene set. The GSEA histograms for the gene sets CEBPA,
E2F1, “granulocyte pathway” and “cell cycle” are shown with the
normalized enrichment score (NES) and p-values.
Additional file 6: Table S3. Chromosomal coordinates and TCONS
names of validated C/EBPα -up regulated (Lnc-CUs) and -down-regulated
(Lnc-DCs) lncRNAs.
Additional file 7: Figure S3. Overlap between lncRNAs identified in
this study used previously generated ChIP data sets for CEBPB and CEBPD
in K562 cells.
Additional file 8: Table S4. Intersection between CEBPB ChiP-seq data
CEBPA upregulated lncRNAs.
Additional file 9: Table S5. Intersection between CEBPD ChiP-seq data
CEBPA upregulated lncRNAs.
Additional file 10: Table S6. Intersection between CEBPB ChiP-seq
data CEBPA downregulated lncRNAs.
Additional file 11: Table S7. Intersection between CEBPD ChiP-seq
data CEBPA downregulated lncRNAs.
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